These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 23343689)

  • 1. The role of uric acid in the pathogenesis of human cardiovascular disease.
    Kanbay M; Segal M; Afsar B; Kang DH; Rodriguez-Iturbe B; Johnson RJ
    Heart; 2013 Jun; 99(11):759-66. PubMed ID: 23343689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and preeclampsia.
    Lam C; Lim KH; Kang DH; Karumanchi SA
    Semin Nephrol; 2005 Jan; 25(1):56-60. PubMed ID: 15660336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?
    Zharikov SI; Swenson ER; Lanaspa M; Block ER; Patel JM; Johnson RJ
    Med Hypotheses; 2010 Jun; 74(6):1069-74. PubMed ID: 20064695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of endothelial dependent vasodilation in patients with hyperuricemia.
    Kato M; Hisatome I; Tomikura Y; Kotani K; Kinugawa T; Ogino K; Ishida K; Igawa O; Shigemasa C; Somers VK
    Am J Cardiol; 2005 Dec; 96(11):1576-8. PubMed ID: 16310444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid and cardiovascular risk: state of the art and perspectives.
    Fenech G; Rajzbaum G; Mazighi M; Blacher J
    Joint Bone Spine; 2014 Oct; 81(5):392-7. PubMed ID: 24565888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
    Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
    Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights.
    Gulab A; Torres R; Pelayo J; Lo KB; Shahzad A; Pradhan S; Rangaswami J
    Expert Rev Cardiovasc Ther; 2021 Jun; 19(6):547-556. PubMed ID: 34112023
    [No Abstract]   [Full Text] [Related]  

  • 11. Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage?
    Stellato D; Morrone LF; Di Giorgio C; Gesualdo L
    Intern Emerg Med; 2012 Feb; 7(1):5-8. PubMed ID: 21842242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and cardiovascular effects of chronic mild hyperuricemia in rodents.
    Park SK; Rosenthal TR; Williams JS; Shelton JM; Takahashi M; Zhang S; Bobulescu IA
    J Investig Med; 2018 Oct; 66(7):1037-1044. PubMed ID: 30042113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.
    Viazzi F; Leoncini G; Ratto E; Pontremoli R
    J Clin Hypertens (Greenwich); 2006 Jul; 8(7):510-8. PubMed ID: 16849905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid and the vasculature.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 2006 May; 8(2):116-9. PubMed ID: 16672143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F; Leoncini G; Pontremoli R
    Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
    Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
    J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
    Kanellis J; Kang DH
    Semin Nephrol; 2005 Jan; 25(1):39-42. PubMed ID: 15660333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid and cardiovascular risk: What genes can say.
    Kei A; Koutsouka F; Makri A; Elisaf M
    Int J Clin Pract; 2018 Jan; 72(1):. PubMed ID: 29250870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.